These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 817424)
1. Limitations of diazoxide reversal of vasospasm. Heros RC; Lavyne MH; Zervas NT Stroke; 1976; 7(2):118-20. PubMed ID: 817424 [TBL] [Abstract][Full Text] [Related]
2. Side effects of diazoxide. Kumar GK; Dastoor FC; Robayo JR; Razzaque MA JAMA; 1976 Jan; 235(3):275-6. PubMed ID: 946045 [TBL] [Abstract][Full Text] [Related]
3. Treatment of experiment delayed cerebral arterial spasm with a beta2-adrenergic stimulator and a phosphodiesterase inhibitor. Norwood CW; Poole J; Moody D J Neurosurg; 1976 Nov; 45(5):491-7. PubMed ID: 823307 [TBL] [Abstract][Full Text] [Related]
5. Side effects of spasmolytic agents in the monkey. Intracisternal phenoxybenzamine and phentolamine. Martins AN; Wiley JK J Neurosurg; 1973 Nov; 39(5):629-35. PubMed ID: 4200598 [No Abstract] [Full Text] [Related]
6. Reversal of cerebral vasospasm using an intrathecally administered nitric oxide donor. Wolf EW; Banerjee A; Soble-Smith J; Dohan FC; White RP; Robertson JT J Neurosurg; 1998 Aug; 89(2):279-88. PubMed ID: 9688124 [TBL] [Abstract][Full Text] [Related]
7. Effects of chlorpromazine on experimental delayed cerebral vasospasm. Nakano M; Tani E; Fukumori T; Yokota M J Neurosurg; 1984 Nov; 61(5):857-63. PubMed ID: 6491731 [TBL] [Abstract][Full Text] [Related]
12. Effect of BQ-123 and tissue plasminogen activator on vasospasm after subarachnoid hemorrhage in monkeys. Kim CJ; Bassiouny M; Macdonald RL; Weir B; Johns LM Stroke; 1996 Sep; 27(9):1629-33. PubMed ID: 8784140 [TBL] [Abstract][Full Text] [Related]
13. Individual titration of diazoxide dosage in the treatment of severe hypertension. Ram CV; Kaplan NM Am J Cardiol; 1979 Mar; 43(3):627-30. PubMed ID: 420113 [TBL] [Abstract][Full Text] [Related]
14. Effect of intracisternal phentolamine on cerebral blood flow after subarachnoid injection of blood. Martins AN; Newby N; Doyle TF; Kobrine AI; Ramirez A J Neurosurg; 1976 Mar; 44(3):353-8. PubMed ID: 814210 [TBL] [Abstract][Full Text] [Related]
15. Observations on the effects of intrathecal papaverine in experimental vasospasm. Ogata M; Marshall BM; Lougheed WM J Neurosurg; 1973 Jan; 38(1):20-5. PubMed ID: 4629882 [No Abstract] [Full Text] [Related]
16. Effect of 5-lipoxygenase inhibitor on experimental delayed cerebral vasospasm. Yokota M; Tani E; Maeda Y; Kokubu K Stroke; 1987; 18(2):512-8. PubMed ID: 3564111 [TBL] [Abstract][Full Text] [Related]
17. Effects of induced hypotension during experimental vasospasm: a neurological, electrophysiological, and pathological analysis. Kaplan BJ; Gravenstein N; Friedman WA; Blackmore JA; Day AL Neurosurgery; 1986 Jul; 19(1):41-8. PubMed ID: 3748337 [TBL] [Abstract][Full Text] [Related]
18. Topical lidocaine in treatment of cerebral vasospasm. Giannotta SL; Kindt GW; Haar FL Surg Neurol; 1975 Jul; 4(1):13-6. PubMed ID: 1166396 [TBL] [Abstract][Full Text] [Related]
19. Reversal and prevention of cerebral vasospasm by intracarotid infusions of nitric oxide donors in a primate model of subarachnoid hemorrhage. Pluta RM; Oldfield EH; Boock RJ J Neurosurg; 1997 Nov; 87(5):746-51. PubMed ID: 9347984 [TBL] [Abstract][Full Text] [Related]
20. Hypotension and bradycardia following diazoxide and hydralazine therapy. Mizroch S; Yurasek M JAMA; 1977 Jun; 237(23):2471-2. PubMed ID: 576958 [No Abstract] [Full Text] [Related] [Next] [New Search]